| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. | Director | Common Stock | 255K | $293K | $1.15 | Aug 25, 2025 | Direct |
| Opus Genetics, Inc. | Director | Stock Option (Right to Buy) | 79.6K | Apr 30, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | Aug 25, 2025 | 1 | $100K | 4 | Aug 27, 2025 | Director |
| IRD | Opus Genetics, Inc. | Apr 30, 2025 | 2 | $0 | 4 | May 2, 2025 | Director |
| OCUP | Ocuphire Pharma, Inc. | Jun 11, 2024 | 2 | $0 | 4 | Jun 13, 2024 | Director |
| OCUP | Ocuphire Pharma, Inc. | Jun 6, 2023 | 2 | $0 | 4 | Jun 8, 2023 | Director |
| OCUP | Ocuphire Pharma, Inc. | Dec 31, 2022 | 1 | $0 | 5 | Feb 14, 2023 | Director |
| OCUP | Ocuphire Pharma, Inc. | Oct 19, 2022 | 2 | $0.16 | 4 | Oct 20, 2022 | Director |
| OCUP | Ocuphire Pharma, Inc. | Jun 13, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
| OCUP | Ocuphire Pharma, Inc. | Dec 31, 2021 | 1 | $0 | 5 | Feb 14, 2022 | Director |
| OCUP | Ocuphire Pharma, Inc. | Jun 7, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |